We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,679 hedge funds and large institutions have $260B invested in Johnson & Johnson in 2023 Q3 according to their latest regulatory filings, with 151 funds opening new positions, 1,220 increasing their positions, 1,999 reducing their positions, and 181 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more call options, than puts

Call options by funds: $3.26B | Put options by funds: $2.81B

0.63% less ownership

Funds ownership: 69.83%69.2% (-0.63%)

2% less funds holding

Funds holding: 3,7523,679 (-73)

13% less capital invested

Capital invested by funds: $300B → $260B (-$40B)

17% less first-time investments, than exits

New positions opened: 151 | Existing positions closed: 181

19% less funds holding in top 10

Funds holding in top 10: 457370 (-87)

39% less repeat investments, than reductions

Existing positions increased: 1,220 | Existing positions reduced: 1,999

Holders
3,679
Holders Change
-73
Holders Change %
-1.95%
% of All Funds
58.38%
Holding in Top 10
370
Holding in Top 10 Change
-87
Holding in Top 10 Change %
-19.04%
% of All Funds
5.87%
New
151
Increased
1,220
Reduced
1,999
Closed
181
Calls
$3.26B
Puts
$2.81B
Net Calls
+$450M
Net Calls Change
-$1.15B
Name Holding Trade Value Shares
Change
Change in
Stake
Hudson Bay Capital Management
676
Hudson Bay Capital Management
Connecticut
$15.6M +$14M +85,000 +567%
BWP
677
Baldwin Wealth Partners
Massachusetts
$15.6M -$310K -1,880 -2%
VVP
678
Venture Visionary Partners
Ohio
$15.6M +$61.5K +373 +0.4%
TRCT
679
Tower Research Capital (TRC)
New York
$15.6M +$10.1M +61,478 +160%
TTWM
680
TCV Trust & Wealth Management
Virginia
$15.5M +$238K +1,445 +1%
ECG
681
Edge Capital Group
Georgia
$15.5M +$845K +5,123 +5%
MLICM
682
Metropolitan Life Insurance Company (MetLife)
New York
$15.5M -$2.25M -13,621 -12%
RMCM
683
Reynders McVeigh Capital Management
Massachusetts
$15.5M -$481K -2,913 -3%
BCV
684
Banque Cantonale Vaudoise
Switzerland
$15.5M -$17M -102,903 -51%
BFEC
685
Benjamin F. Edwards & Company
Missouri
$15.5M -$722K -4,376 -4%
CAM
686
Congress Asset Management
Massachusetts
$15.5M -$34.5K -209 -0.2%
MSS
687
Mitchell Sinkler & Starr
Pennsylvania
$15.4M +$2.91M +17,642 +22%
NPF
688
Norris Perne & French
Michigan
$15.4M +$316K +1,916 +2%
ISL
689
Ingalls & Snyder LLC
New York
$15.4M -$2.65M -16,048 -14%
PAM
690
Palisade Asset Management
Minnesota
$15.3M +$42.6K +258 +0.3%
BG
691
Bollard Group
Massachusetts
$15.3M +$112K +679 +0.7%
PI
692
Pettee Investors
Connecticut
$15.2M
FNBOO
693
First National Bank of Omaha
Nebraska
$15.2M -$1.07M -6,483 -6%
PWM
694
Perigon Wealth Management
California
$15.1M -$1.02M -6,196 -6%
EW
695
Evoke Wealth
California
$15.1M -$193K -1,172 -1%
ECM
696
Estabrook Capital Management
New York
$15.1M +$49K +297 +0.3%
LNWWM
697
Laird Norton Wetherby Wealth Management
California
$15.1M -$558K -3,381 -3%
LS
698
Livforsakringsbolaget Skandia
Sweden
$15M -$763K -4,627 -5%
M
699
MOTCO
Texas
$15M -$403K -2,445 -2%
GT
700
Greenleaf Trust
Michigan
$15M -$408K -2,473 -3%

JNJ Hedge Fund Activity: Q3 2023 in Review

3,679 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2023, worth a combined $260B — down 13% from $300B a quarter earlier.

Sellers outnumbered buyers: 181 funds closed out of JNJ and 151 opened new positions — a net loss of 30 holders — while 1,999 trimmed existing stakes and 1,220 added.

The largest buyer was Goldman Sachs, adding an estimated $394M. The largest seller was Vanguard Group, cutting an estimated $3B.

  • 3,679 institutional investors held Johnson & Johnson (JNJ) as of Q3 2023, down from 3,752 in Q2 2023.
  • Funds reported $260B of Johnson & Johnson stock for Q3 2023, down 13% quarter-over-quarter.
  • 151 funds opened new Johnson & Johnson positions in Q3 2023 and 181 closed out, a net change of -30 holders.
  • The largest Johnson & Johnson buyer in Q3 2023 was Goldman Sachs, an estimated $394M added.
  • The largest Johnson & Johnson seller in Q3 2023 was Vanguard Group, an estimated $3B sold.

Based on aggregated 13F filings for Q3 2023.